BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28730868)

  • 1. Intercontinental validation of brain volume measurements using MSmetrix.
    Finkelsztejn A; Fragoso YD; Bastos EA; Duarte JA; Varela JS; Houbrechts R; Sima D; Van Hecke W
    Neuroradiol J; 2018 Apr; 31(2):147-149. PubMed ID: 28730868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
    Steenwijk MD; Amiri H; Schoonheim MM; de Sitter A; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2017; 15():843-853. PubMed ID: 28794970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
    Wang C; Beadnall HN; Hatton SN; Bader G; Tomic D; Silva DG; Barnett MH
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):754-7. PubMed ID: 27071647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
    Lysandropoulos AP; Absil J; Metens T; Mavroudakis N; Guisset F; Van Vlierberghe E; Smeets D; David P; Maertens A; Van Hecke W
    Brain Behav; 2016 Feb; 6(2):e00422. PubMed ID: 27110445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of clinical findings and brain volume data in multiple sclerosis.
    Fragoso YD; Wille PR; Abreu M; Brooks JBB; Dias RM; Duarte JA; Farage L; Finkelsztejn A; Frohlich AC; Goncalves MVM; Guedes BVS; Medeiros L; Oliveira RA; Ribas FD; da Rocha FCG; Santos GAC; Scorcine C; da Silveira GL; Spedo CT; Tauil CB; Varela JS; Vieira VLF;
    J Clin Neurosci; 2017 Oct; 44():155-157. PubMed ID: 28676309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
    Jain S; Sima DM; Ribbens A; Cambron M; Maertens A; Van Hecke W; De Mey J; Barkhof F; Steenwijk MD; Daams M; Maes F; Van Huffel S; Vrenken H; Smeets D
    Neuroimage Clin; 2015; 8():367-75. PubMed ID: 26106562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain and grey matter volume of Japanese patients with multiple sclerosis.
    Akaishi T; Nakashima I; Mugikura S; Aoki M; Fujihara K
    J Neuroimmunol; 2017 May; 306():68-75. PubMed ID: 28385190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.
    D'hooghe MB; Gielen J; Van Remoortel A; D'haeseleer M; Peeters E; Cambron M; De Keyser J; Nagels G
    J Magn Reson Imaging; 2019 May; 49(5):1312-1321. PubMed ID: 30597656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Atrophy Early in Multiple Sclerosis: Third Ventricle Volumetry versus Planimetry.
    Lutz T; Bellenberg B; Schneider R; Weiler F; Köster O; Lukas C
    J Neuroimaging; 2017 May; 27(3):348-354. PubMed ID: 27897360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of MR volumetry in brain atrophy assessment in multiple sclerosis: A review of the literature.
    Marciniewicz E; Podgórski P; Sąsiadek M; Bladowska J
    Adv Clin Exp Med; 2019 Jul; 28(7):989-999. PubMed ID: 30729761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
    Sastre-Garriga J; Pareto D; Rovira À
    Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
    Pareto D; Sastre-Garriga J; Aymerich FX; Auger C; Tintoré M; Montalban X; Rovira A
    Neuroradiology; 2016 May; 58(5):467-74. PubMed ID: 26847633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain MRI atrophy quantification in MS: From methods to clinical application.
    Rocca MA; Battaglini M; Benedict RH; De Stefano N; Geurts JJ; Henry RG; Horsfield MA; Jenkinson M; Pagani E; Filippi M
    Neurology; 2017 Jan; 88(4):403-413. PubMed ID: 27986875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and Brain Atrophy in Multiple Sclerosis.
    Ghione E; Bergsland N; Dwyer MG; Hagemeier J; Jakimovski D; Paunkoski I; Ramasamy DP; Carl E; Hojnacki D; Kolb C; Weinstock-Guttman B; Zivadinov R
    J Neuroimaging; 2019 Jul; 29(4):527-535. PubMed ID: 31074192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis.
    Ruberte E; Sinnecker T; Amann M; Gaetano L; Naegelin Y; Penner IK; Kuhle J; Derfuss T; Kappos L; Granziera C; Wuerfel J; Yaldizli Ö
    Eur Neurol; 2018; 80(3-4):207-214. PubMed ID: 30605898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.